Mode
Text Size
Log in / Sign up

Meta-analysis of 7,048 first-time stroke patients across six countries reports post-stroke cognitive impairment incidence ratesHalf of stroke survivors face memory loss

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that post-stroke cognitive impairment affects approximately 46% of first-time stroke patients, with higher rates in females and those with hemorrhagic stroke.

A systematic review and meta-analysis pooled data from studies involving 7,048 first-time stroke patients across six countries to assess the incidence of post-stroke cognitive impairment (PSCI). The analysis stratified patients by sex, stroke subtype, comorbidities, and age to explore variability in outcomes. No specific medication interventions were evaluated in this observational synthesis.

The overall incidence of PSCI was 46% (95% CI 36–57). Subgroup analyses indicated that PSCI prevalence was 45% in females compared to 38% in males. Patients with hemorrhagic stroke exhibited a prevalence of 54%, whereas ischemic stroke patients had a prevalence of 44%. Comorbidities also influenced risk; patients with hypertension showed a 38% prevalence versus 32% in those without, while those with diabetes had a 44% prevalence compared to 36% without. Similarly, hyperlipidemia was associated with a 46% prevalence versus 40% in patients without this condition. Patients aged over 60 years had a 44% incidence.

Safety and tolerability data were not reported. A critical limitation of this meta-analysis was substantial statistical heterogeneity, with an I² statistic of 98.63%, suggesting significant variation between included studies. Funding sources and potential conflicts of interest were not reported. Because the evidence is observational, causal inferences regarding specific risk factors cannot be made. Clinicians should recognize these high baseline rates of cognitive impairment in diverse stroke populations when planning long-term care and rehabilitation strategies.

Imagine waking up after a stroke, only to realize you forgot why you walked into the room. You know you had a stroke, but the real struggle begins when you can't remember your own name or the faces of your loved ones. This is not just a minor inconvenience; it is a silent crisis affecting nearly half of all first-time stroke patients.

Post-stroke cognitive impairment (PSCI) happens when a stroke damages the parts of the brain that handle thinking, memory, and focus. It is different from the physical weakness people often see on TV. A person might walk fine but cannot follow a conversation or manage their daily tasks.

This condition is very common. It affects men and women, but it hits harder in older adults. Many patients leave the hospital feeling physically recovered, only to struggle at home because their brain is not working as well as it used to. Current treatments focus heavily on moving muscles and fixing blood flow. But there is no standard way to fix the thinking skills lost after a stroke.

The surprising shift

For years, doctors assumed that if a patient survived the physical attack on their brain, their mind would mostly recover. We thought the brain could heal itself quickly. But this study changes that view. It shows that thinking problems are not rare side effects; they are the rule for many survivors.

But here is the twist. The risk is not spread evenly. Some groups face a much higher chance of these memory and thinking issues than others. Understanding who is at risk is the first step toward helping them.

What scientists didn't expect

To understand how this works, think of your brain like a busy city with millions of workers. A stroke is like a sudden power outage in one neighborhood. The workers there stop working. But the study found that the outage affects the whole city's ability to function.

The research looked at data from thousands of people across six different countries. They combined results to get a clear picture of how often this happens. They checked for common health issues like high blood pressure and diabetes to see how they change the risk.

The main finding is stark: 46% of people having their first stroke will develop cognitive impairment. That means almost one out of every two survivors will face these challenges.

The risk goes up for specific groups. Women are more likely to face this than men. People over the age of 60 are also at higher risk. If you have a hemorrhagic stroke (bleeding in the brain), the chance of cognitive issues is 54%. For those with ischemic stroke (blocked blood flow), it is 44%.

Health conditions play a huge role too. Patients with high blood pressure face a 38% risk. Those without high blood pressure face a 32% risk. People with diabetes have a 44% risk, while those without diabetes have a 36% risk. High cholesterol also increases the risk from 40% to 46%.

This doesn't mean this treatment is available yet.

These numbers are not just statistics; they represent real people struggling to remember their grandchildren or manage their medicine. The study highlights that having these risk factors does not guarantee you will have problems, but it does mean you need to be extra careful.

If you or a loved one has had a stroke, do not ignore changes in memory or thinking. These symptoms are not just "getting old." They are a sign that needs attention.

Talk to your doctor about your thinking skills. Ask for tests that check your memory and focus. Early detection is key. While we do not have a magic cure yet, knowing your risk helps you plan better. Managing blood pressure, sugar, and cholesterol can lower your chances of developing these issues.

The limitations

This study combined data from many smaller studies. While this gives a big picture, it cannot tell us exactly what will happen to any single person. The studies included were done in different places with different methods. This makes the results a strong estimate, but not a perfect prediction for everyone.

We need more research to find ways to fix these thinking problems. Scientists are looking at new drugs and therapies to help the brain heal after a stroke. Until then, the best tool we have is prevention. Controlling your health risks before a stroke happens is the most powerful step you can take.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
ObjectiveTo clarify the incidence of post-stroke cognitive impairment (PSCI) in first-time stroke patients through meta-analysis.MethodsWe conducted a comprehensive search of PubMed, Embase, Web of Science, and the Cochrane Library for studies reporting PSCI incidence up to May 5, 2024. Pooled incidence was calculated using Stata 18.0 with a random-effects model.ResultsA total of 11 publications from six countries with a sample population of 7,048 were included in the final analysis. The overall incidence of PSCI in first-time stroke patients was estimated to be 46% [95% CI (36–57), I2 = 98.63%]. Subgroup analysis showed that the prevalence of PSCI was 38% in male and 45% in female; The prevalence of PSCI was 54% for hemorrhagic stroke and 44% for ischemic stroke; The prevalence of PSCI was 38% in stroke patients possessing hypertension and 32% in stroke patients without hypertension; The prevalence of PSCI was 44% in stroke patients with diabetes and 36% in stroke patients without diabetes; The prevalence of PSCI was 46% in stroke patients with hyperlipidemia and 40% in stroke patients without hyperlipidemia; The incidence of PSCI in stroke patients aged > 60 years was 44%.ConclusionNearly half of patients with first-time stroke develop PSCI and the rate is higher in females, patients aged > 60 years, hemorrhagic stroke subtype, and those with hypertension, diabetes, and hyperlipidemia compared to males, ischemic stroke subtype, and those without underlying diseases.Systematic review registrationThe protocol for this review was registered with the PROSPERO International Prospective Register of Systematic Reviews (CRD42024611457).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.